2024

BIOHARVEST SCIENCES INC. ANNOUNCES COMPLETION OF CONSOLIDATION

2024 /

VANCOUVER, CANADA, and REHOVOT, ISRAEL, June 3, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) announces the completion of the consolidation (the “Consolidation”) of all of its issued and outstanding common shares (“Common Shares”) on the basis of thirty-five (35) pre-Consolidation Common Shares for every one (1) post-Consolidation Common Share. Immediately upon […]

BIOHARVEST SCIENCES INC. ANNOUNCES COMPLETION OF CONSOLIDATION Read More »

BioHarvest Sciences Reports First Quarter 2024 Financial Results

2024 /

Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 Million Vancouver, British Columbia and Rehovot, Israel – May 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today reported

BioHarvest Sciences Reports First Quarter 2024 Financial Results Read More »

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION

2024 /

VANCOUVER, CANADA, and REHOVOT, ISRAEL, May 29, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) announces that it plans to consolidate (the “Consolidation”) its issued and outstanding common shares (“Common Shares”) on the basis of thirty-five (35) pre-Consolidation Common Shares for every one (1) post-Consolidation Common Share. Pursuant to Section 4.6(8) of

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION Read More »

img

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time

2024 /

Vancouver, British Columbia and Rehovot, Israel – May 1, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2nd to discuss recently announced milestone achievements, including full year 2023

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time Read More »

BioHarvest

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

2024, Uncategorized /

Vancouver, British Columbia and Rehovot, Israel – April 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company is also announcing an

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results Read More »

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

2024 /

Vancouver, British Columbia and Rehovot, Israel – April 16, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: a long term lease agreement  for a new 80,000 square ft. facility  in Yavne, Israel, and an

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity Read More »